Article
A polyanhydride-based implantable single dose vaccine platform for long-term immunity
Vaccine
Document Type
Article
Disciplines
Publication Version
Published Version
Publication Date
2-8-2018
DOI
10.1016/j.vaccine.2017.11.067
Abstract
Traditionally, immune priming followed by an antigen-boost is utilized for vaccine-induced protective immunity and maintaining long-term immunity often requires repeated exposure to antigen. Here, a novel single dose vaccination platform designed with gonadotropin releasing hormone multiple antigenic peptide as a model antigen is shown.
Rights
Works produced by employees of the U.S. Government as part of their official duties are not copyrighted within the U.S. The content of this document is not copyrighted.
Language
en
File Format
application/pdf
Citation Information
Robert G. Schaut, Matt T. Brewer, Kriscelle Mendoza, John K. Jackman, et al.. "A polyanhydride-based implantable single dose vaccine platform for long-term immunity" Vaccine Vol. 36 Iss. 7 (2018) p. 1024 - 1025 Available at: http://works.bepress.com/matt-brewer/15/
This article is published as Schaut, Robert G., Matthew T. Brewer, Kriscelle Mendoza, John Jackman, Balaji Narasimhan, and Douglas E. Jones. "A polyanhydride-based implantable single dose vaccine platform for long-term immunity." Vaccine 36, no. 7 (2018): 1024-1025. DOI: 10.1016/j.vaccine.2017.11.067.